咖啡酸衍生物:潜在的选择性抗瘤,抗微生物和抗原动物剂
Miloš Lukáč1, Lívia Slobodníková2, Martin Mrva3
1Department of Chemical Theory of Drugs, Faculty of Pharmacy, Comenius University Bratislava, Odbojárov 10, 832 32 Bratislava, Slovakia.
International journal of molecular sciences
|January 23, 2024
概括
与咖啡酸相比,新的咖啡酸盐 (CAP) 显示出增强的细胞毒性,抗微生物和抗氨基酸活性. 这些衍生物显示出作为选择性抗瘤剂和局部抗微生物药物的潜力.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 有机合成 有机合成
背景情况:
- 咖啡酸 (CA) 是一种天然的植物化合物,具有多种药理上的好处.
- 合成修改天然产品可以增强其治疗潜力.
- 盐代表了一类具有潜在生物活性的化合物.
研究的目的:
- 合成新的咖啡酸衍生物 (CAPs).
- 评估CAPs在体外的细胞毒性,抗菌性,抗真菌性和杀菌性活动.
- 为了比较CAP与其母化合物咖啡酸的疗效.
主要方法:
- 四种不同的咖啡酸盐 (CAPs) 的合成.
- 在体外测试CAP对多个人类癌细胞系的细胞毒性 (HeLa,HCT116,MDA-MB-231,MCF-7,A2058,PANC-1,Jurkat).
- 在体外评估抗微生物活性对抗格拉姆阳性细菌,Candida albicans和致病性阿坎萨摩巴菌株.
- 分别确定细胞毒性和抗菌活性的IC50和MIC值.
主要成果:
- 与CA相比,CAPs对所有测试的癌症细胞系显著增强了细胞毒性活性,特别是对Jurkat细胞 (0.98.5μM) 的IC50值显著低.
- 与CA相比,CAPs表现出对格拉姆阳性细菌和Candida albicans (MIC 1357μM) 的抗微生物活性优越.
- 与CA相比,CAPs对阿坎萨摩巴菌株 (EC50 443125 μM) 的抑制作用有所改善,特别是对A. quina.
结论:
- 合成的咖啡酸盐具有强大和选择性的抗瘤特性.
- 在抗微生物应用中,CAPs是有前途的候选药物,特别是用于局部使用.
- 这些新型衍生品需要进一步研究它们的药物应用.
相关概念视频
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Electron Transport Chain: Complex I and II
13.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.4K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K

![Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60786.jpg&w=3840&q=50)
